Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James F. Young currently holds 61,760 shares of NOVAVAX INC (NVAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James F. Young has been a net seller of NVAX stock. They have purchased $871.0K and sold $6.7M worth of shares.
James F. Young's most recent insider trade was on Jun 21, 2024, when they sold 7,500 shares at $14.09 per share.
James F. Young serves as Executive at NOVAVAX INC (NVAX). They have executed 43 insider transactions totaling $7.6M over their tenure at the company.
James F. Young holds the position of Executive at NOVAVAX INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James F. Young has shown a selling trading pattern, with $871.0K in total purchases and $6.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James F. Young was on Jun 4, 2007, when they sold $5.7M worth of MEDI shares. This transaction involved 97,932 shares at $58.00 per share.
James F. Young currently owns 61,760 shares of NOVAVAX INC (NVAX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James F. Young's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James F. Young has 43 Form 4 filings on record as an insider at NOVAVAX INC.
Set alerts for James F. Young and 40,000+ other insiders.